What amount sold does Araceli Biosciences Inc. report in Form D filings?

The latest linked filings report $2.5M sold across 1 identified offering(s). 1 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Araceli Biosciences Inc.'s most recent SEC filing?

Araceli Biosciences Inc.'s most recent Form D filing was on 2025-12-08.

How many investors does Araceli Biosciences Inc. have?

The most recent Form D filing lists 28 investor(s).

Araceli Biosciences Inc.

CIK: 0001975014·Other Technology·TIGARD, OR

Reported Sold

$2,525,000

Total Filings

Identified Offerings

Last Filed

Dec 8, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

Offering filing timeline

Dec 8, 2025Form D/A — Amendment

Reported sold: $12,236,994 · Target: $14,061,994

No verified predecessor available.

Rule 506(b)·28 investors

Jan 15, 2025Form D — New notice

Reported sold: $2,525,000 · Target: $8,000,351

Rule 506(b)·6 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 1 identified offering

$2,525,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

Matt Beaudet

Executive Officer, Director

Appears on 2 filings

Shawn MacDonald

Executive Officer

Appears on 2 filings

William Cortelyou

Director

Appears on 2 filings

Bruce Rhine

Director

Appears on 2 filings

Sean O'Neill

Director

Appears on 2 filings

J. William Freytag

Director

Appears on 2 filings

Kevin Gabelein

Director

Appears on 2 filings

Kirk Malloy

Director

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Dec 8, 2025	Amendment	$14,061,994	$12,236,994	28
Jan 15, 2025	New	$8,000,351	$2,525,000	6

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Rapta Inc.

Other Technology

Offering target: $10,835,253

Filed Sep 14, 2026